All filters
Slidesets
Evolving Treatment Paradigm and Future Landscape in HCC - Masafumi Ikeda, MD
Presented at:
Tokyo Hepatitis Clinical Forum 2019
Slidesets
Ontwikkelingen op het gebied van HIV Cure - Annemarie Wensing, MD, PhD
Presented at:
Post-CROI Symposium 2019
Slidesets
Ontwikkelingen HIV resistentie en eliminatie - Charles Boucher, MD, PhD
Presented at:
Post-CROI Symposium 2019
Slidesets
Farmacologie bij CROI 2019: focus op zwangerschap en pediatrie - David Burger, PharmD, PhD
Presented at:
Post-CROI Symposium 2019
Slidesets
HIV: een gewichtige ziekte - Andy Hoepelman, MD, PhD
Presented at:
Post-CROI Symposium 2019
Slidesets
Ontwikkelingen nieuwe ARV en PrEP in 2019 - Kees Brinkman, MD, PhD
Presented at:
Post-CROI Symposium 2019
Slidesets
The African Centres for Diseases Control and Prevention- John Nkengasong, PhD, MSC
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2019
Slidesets
Rift Valley Fever - David Soti, MBChB, MPH
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2019
Slidesets
Risk Communication and Risk Perception in the 2014-2015 Ebola Outbreak in Sierra Leone - Maike Winters
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2019
Slidesets
Propagation of Drug Resistance by Clinicians Through Concurrent Treatment of Malaria and Typhoid Fever Among Patients Presenting with Febrile Illnesses in a Municipal Hospital in Ghana 2017 - Tanko Rufai
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2019
Slidesets
A Situation Analysis of Antibiotic Consumption and Its Potential Contribution to Antimicrobial Resistance in Nigeria - Abiodun Egwuenu
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2019
Slidesets
Lunch Symposium - challenges in EID preparedness, the Yellow fever case - Marion Koopmans, DVM, PhD
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2019
Slidesets
Clinical case: Researcher perspective - Tendani Gaolathe, MD
Presented at:
International Workshop on HIV & Women 2019
Slidesets
INSTI exposure and neural tube defects – data from antiretroviral pregnancy registry - Jessica Albano, PhD, MPH
Presented at:
International Workshop on HIV & Women 2019
Slidesets
Clinical case: Policy implications - Meg Doherty, MD, PhD
Presented at:
International Workshop on HIV & Women 2019
Slidesets
Congenital anomalies in infants of Canadian women exposed to antiretrovirals including dolutegravir - Deborah Money, MD
Presented at:
International Workshop on HIV & Women 2019
Slidesets
Clinical development strategy to inform dosing of antiretroviral drugs in women: dolutegravir as a case study - Kimberly Adkison, PhD
Presented at:
International Workshop on HIV & Women 2019
Slidesets
Emerging drug delivery systems for treatment and prevention of HIV- Kimberly Scarsi, PharmD, MS, FCCP
Presented at:
International Workshop on HIV & Women 2019
Slidesets
HIV risk and characteristics of women seeking PrEP in a US demonstration project - Jill Blumenthal, MD
Presented at:
International Workshop on HIV & Women 2019
Slidesets
Innovative intervention for pregnant and breastfeeding adolescent mothers to enhance viral suppression in Homa Bay County, Kenya - Elizabeth Okoth (presented by N. Rakhmanina), MPH
Presented at:
International Workshop on HIV & Women 2019
Slidesets
High PrEP uptake among HIV-exposed women with pregnancy plans in South Africa - Lynn Matthews, MD
Presented at:
International Workshop on HIV & Women 2019
Slidesets
Non-Vaccine Oncogenic HPV Persistence Among HPV-Vaccinated Women Living with HIV - Elisabeth McClymont
Presented at:
International Workshop on HIV & Women 2019
Slidesets
Cardiac Muscle Health Among Women Aging with HIV - Markella Zanni, MD
Presented at:
International Workshop on HIV & Women 2019
Slidesets
Dolutegravir pharmacokinetics during pregnancy and postpartum - Angela Colbers, PhD
Presented at:
International Workshop on HIV & Women 2019